• share
• favorite_border

A group of physicians and scientists with the University of Miami Miller School of Medicine are releasing an important study that will be published in the journal Pediatrics on Thursday, showing that COVID-19 can cross into the placenta of pregnant women and cause brain injury in newborns, as evidenced with 2 cases they treated here in Miami. One of the infants also died at about 13 months old. Further testing of the infant’s brain specimen showed that the virus was still present in the brain at the time of death—which was over a year after birth.

• share
• favorite_border

Researchers have shown that, in two cases, COVID-19 infection breached the placenta and caused brain damage in the newborn.

• share
• favorite_border

Cleveland Clinic researchers found 41% of patients with long COVID, had moderate to severe sleep disturbances. The retrospective analysis also identified risk factors for moderate to severe sleep disturbances, including race, hospitalization for COVID-19, greater anxiety severity and fatigue. After adjusting for demographics, Black patients were three times more likely to develop these sleep disturbances. The findings were published in Journal of General Internal Medicine.

• share
• favorite_border

Teens’ trust in the news they consume on social media – or lack of it – may be key to whether it supports or detracts from their well-being, according to Cornell-led psychology research.

• share
• favorite_border

Recent study reveals neurodegenerative biomarkers after COVID-19, gives clues for monitoring and potential treatment of long COVID

• share
• favorite_border

The COVID-19 pandemic has been accompanied by an unprecedented global infodemic that has led to confusion about the benefits of medical and public health interventions, with substantial impact on risk-taking and health-seeking behaviors, eroding trust in health authorities and compromising the effectiveness of public health responses and policies.

• share
• favorite_border

A study by researchers at Washington University School of Medicine in St. Louis shows that vaccinating people with updated boosters as new variants of the virus that cause COVID-19 emerge could shore up population immunity even as the virus mutates, and thereby prevent another deadly COVID-19 wave.

• share
• favorite_border

New research from the University at Buffalo provides the most comprehensive assessment to date of drinking patterns during the COVID-19 pandemic and their association with four clinically prevalent mental health disorders in the U.S.

• share
• favorite_border

In a study among residents of Ventura County, California, rates of sudden cardiac arrest rose sharply during the COVID-19 pandemic.

• share
• favorite_border

In a new study, researchers analyzed data from Cali, Colombia, to develop a model that provides a template for tracking data, predicting transmission, and informing health surveillance systems.

• share
• favorite_border

The COVID-19 pandemic posed an immense challenge on the health care industry in 2020 and 2021. While hospitals were inundated with COVID-19 cases, other illnesses such as respiratory syncytial virus (RSV) saw a decrease in hospital visits, particularly in the fourth quarter of 2020 and the first quarter of 2021.

• share
• favorite_border

From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.

• share
• favorite_border

Researchers have designed a molecule that slows the effects of one of SARS-CoV-2's more dangerous components – an enzyme called a protease that cuts off the immune system's communications and helps the virus replicate. While much more needs to happen to develop a drug, scientists can begin to imagine what that drug could look like – thanks to new images of the molecule bound to the protease.

• share
• favorite_border

A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

• share
• favorite_border

Scientists report using a single-atom-thick nanomaterial to build a device that can simultaneously detect the presence of the viruses that cause COVID-19 and the flu — at much lower levels and much more quickly than conventional tests for either. They will present their results at ACS Spring 2023.

• share
• favorite_border

Researchers examined how a country’s number of published 3D protein structures for coronaviruses correlated with its economic output and population. The findings reveal important insights into how different countries' research establishments respond to disease outbreaks.

• share
• favorite_border

People infected with SARS-CoV-2, the virus that causes COVID-19, may experience genome structure changes that not only may explain our immunological symptoms after infection, but also potentially link to long COVID, according to a new study by researchers at UTHealth Houston.

• share
• favorite_border

Nearly a third of Americans (29%) say COVID-19 made them more worried than ever about having obesity prompting about 28 million people to consider weight-loss methods they hadn’t thought about before the pandemic began, including nearly 6.4 million thought about turning to either weight-loss surgery or taking prescription anti-obesity drugs for the first time, according to a new survey whose findings were published online in the peer-reviewed journal, Surgery for Obesity and Related Diseases (SOARD).

• share
• favorite_border

UC San Diego researchers describe why SARS-CoV-2 subvariants spread more rapidly than the original virus strain, and how an early treatment might have made people more susceptible to future infections.

• share
• favorite_border

Post-acute sequelae SARS-CoV-2 infection (PASC), also known as long-haul COVID-19, is positively associated with posttraumatic stress disorder (PTSD), says new research presented at Physiatry ’23, the Association of Academic Physiatrists (AAP) annual meeting.

• share
• favorite_border

A UCLA-led team has developed an inexpensive, universal oral COVID-19 vaccine that prevented severe respiratory illness and weight loss when tested in hamsters, which are naturally susceptible to SARS-CoV-2. It proved as effective as vaccines administered by injection or intranasally in the research. If ultimately approved for human use, it could be a weapon against all COVID-19 variants and boost uptake, particularly in low- and middle-income countries, and among those with an aversion to needles.

• share
• favorite_border

Early COVID-19 pandemic suspicions about dogs’ resistance to the disease have given way to a long-haul clinical data gap as new variants of the virus have emerged.

• share
• favorite_border

The magnitude and quality of a key immune cell’s response to vaccination with two doses of the Pfizer-BioNTech COVID-19 vaccine were considerably lower in people with prior SARS-CoV-2 infection compared to people without prior infection, a study has found.

• share
• favorite_border

Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.

• share
• favorite_border

New research from Leela Nageswaran, assistant professor of operations management in the University of Washington Foster School of Business, considers whether individuals should be able to select their vaccine type.

• share
• favorite_border

Anthony DiStefano, professor of public health at Cal State Fullerton, believes that the sudden social isolation that occurred during the COVID-19 pandemic had an influence on mental health and drug overdose deaths.

• share
• favorite_border

Research is shedding light on why ‘breakthrough’ Omicron infections occur in vaccinated individuals and suggests those who are both vaccinated and experienced previous infection have better protection against getting sick again.

• share
• favorite_border

COVID-19 has caused significant global panic after its rapid emergence more than 3 years ago.